The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...

HistoSonics is shopping for a potential buyer of its approach to destroying liver tumors with focused sound waves, according ...

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC ... of this study was to evaluate the combined use of the ultrasound examination and the assessment of the patients' clinical ...

The FDA has granted full approval to Bristol Myers Squibb’s (BMS) dual immunotherapy regimen of Opdivo (nivolumab) plus Yervoy (ipilimumab) for adults with unresectable or metastatic hepatocellular ...

as a first-line treatment for adults with unresectable or metastatic hepatocellular carcinoma (HCC). Median overall survival, the primary outcome measure, was 23.7 months in those randomized to ...

A new study uses DNA origami structures to selectively deliver fluorescent imaging agents to pancreatic cancer cells without affecting normal cells. The study, led by University of Illinois Urbana ...

Premium is the first FDA-approved breast ultrasound supplemental screening technology specifically designed for detecting cancer in dense breasts SenoBright™ HD and SerenaBright™ are the first ...

Its success as an imaging modality is also what makes it so challenging to constrain. CT has become essential to the diagnostic process for many serious conditions, from trauma to cancer," the ...